Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
Frontiers | Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies
Peptide Blocking: Novus Biologicals
SARS-CoV-2 Neutralization Antibody Detection Kit | MBL Life Sience -ASIA-
What is antibody therapy?
A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2 | bioRxiv
Research and Development Progress of a SARS-CoV-2 Neutralizing Antibody
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect
LIBRA-seq: Accelerating antibody discovery
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective | SpringerLink
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: Trends in Immunology
Developing reagents for SARS-CoV-2 neutralizing antibody detection
Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS